Liselotte Fierens
0000-0002-4893-7682
11 papers found
Refreshing results…
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies (vol 16, pg 1059, 2022)
Vaccination Coverage Increased Significantly After the Implementation of a Vaccination Tool in the Electronic Patient Health Record
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies
Implementation of a vaccination tool in the electronic patient health record significantly increases vaccination coverage
Inflammatory Bowel Disease-related Behaviours [IBD-Bx] Questionnaire: Development, Validation and Prospective Associations with Fatigue
P484 Remote monitoring allows an individualized approach and showed excellent usability at the infusion unit
P280 Introduction of subcutaneous infliximab CT-P13 and vedolizumab in daily clinical practice: outstanding questions demonstrate the need for post-marketing studies
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium – a validation of the Dutch rating form
Disease-Specific Avoidance Is Associated With Fatigue in Patients With Inflammatory Bowel Disease
Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients
Missing publications? Search for publications with a matching author name.